Participant flow

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer · Source last updated 2026-08-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Patients receive oral treatment with olaparib 300mg twice daily in combination with abiraterone 1000mg once daily

   id

   FG000

   title

   Olaparib 300 mg bd + Abiraterone 1000 mg qd

2. description

   Patients receive oral treatment with placebo twice daily in combination with abiraterone 1000mg once daily.

   id

   FG001

   title

   Placebo bd + Abiraterone 1000 mg qd

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         168

      2. group Id

         FG001

         num Subjects

         203

      type

      Death

   2. reasons

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         2

      type

      Other

   3. reasons

      1. group Id

         FG000

         num Subjects

         1

      2. group Id

         FG001

         num Subjects

         1

      type

      Failure to meet randomisation criteria

   4. reasons

      1. group Id

         FG000

         num Subjects

         14

      2. group Id

         FG001

         num Subjects

         10

      type

      Patient decision

   5. reasons

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         1

      type

      Screen failure

   6. reasons

      1. group Id

         FG000

         num Subjects

         210

      2. group Id

         FG001

         num Subjects

         178

      type

      Patients ongoing study at data cut off

   7. reasons

      1. group Id

         FG000

         num Subjects

         4

      2. group Id

         FG001

         num Subjects

         2

      type

      Lost to Follow-up

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         399

      2. group Id

         FG001

         num Subjects

         397

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         399

      2. group Id

         FG001

         num Subjects

         397

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice